Fundraising Fox

Clearmind Medicine

NASDAQ: CMND

Vancouver · Canada (Federal Level) corporation · 1 known investors

clearmindmedicine.com

Clearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).

BiotechDigital HealthHealthtechMental Health

Founders & leadership

DA
Dr. Adi Zuloff-ShaniBiomedical Research and Development Executive
ARAlan Rootenberg
Alan RootenbergExecutive
PM
Prof. Mark HadenExecutive
AZ
Adi Zuloff-ShaniCEO
MHMark Haden
Mark HadenVP Business Development

Board

YSYehonatan Shachar
Yehonatan ShacharBoard director
AIAsaf Itzhaik
Asaf ItzhaikBoard director
AWAmitay Weiss
Amitay WeissBoard director
OAOz Adler
Oz AdlerBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 1 round · 2024

$2.4MraisedFeb 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yehonatan ShacharDirector
  • Asaf ItzhaikDirector
  • Dr. Adi Zuloff-ShaniExecutive Officer
  • Amitay WeissDirector
  • Alan RootenbergExecutive Officer
  • Oz AdlerDirector
  • Prof. Mark HadenExecutive Officer
Offering amount
$2.4M
Amount sold
$2.4M
Sales commissions
$192K
Placement agents
Aegis Capital Corp.
First sale
Jan 2024
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Clearmind Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Clearmind Medicine do?
Clearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).
Who are Clearmind Medicine's investors?
Clearmind Medicine's investors include Khosla Ventures.
How much funding has Clearmind Medicine raised?
Clearmind Medicine has disclosed $2.4M raised across 1 round.
Where is Clearmind Medicine headquartered?
Clearmind Medicine is headquartered in Vancouver.